Weishi Li works with life sciences clients on cross-border transactions. Weishi leads the firm's China life sciences transaction practice, and previously served for five years as Managing Partner of the Shanghai office.

Weishi has extensive experience assisting Western and Chinese life sciences companies in structuring and negotiating cross-border commercial, corporate, and partnering transactions involving China, including strategic collaborations, joint ventures, licensing, acquisitions, co-promotion, and distribution arrangements. As a registered U.S. patent attorney with a Ph.D. in microbiology and substantial food and drug regulatory experience, Weishi has a deep understanding of the complex issues confronting the industry and is well-versed in helping clients tackling such issues.